Literature DB >> 11446844

Prevalence of urinary incontinence in women with cystic fibrosis.

M Cornacchia1, A Zenorini, S Perobelli, L Zanolla, G Mastella, C Braggion.   

Abstract

OBJECTIVE: To determine the prevalence of urinary incontinence (UI) in female patients (aged > or = 15 years) attending a cystic fibrosis (CF) centre, in whom stress UI could be common, as chronic coughing and sputum production are frequent symptoms associated with progressive lung disease in these patients. PATIENTS AND METHODS: An anonymous questionnaire was completed by 176 women with CF (mean age 24.6 years, SD 5.8) during routine assessments as outpatients.
RESULTS: In all, 72 patients (41%) were classified as never incontinent; occasional UI was reported in 61 women (35%). Regular UI, occurring twice or more a month for at least two consecutive months in the last year, was reported in 43 patients (24%). Regular UI was associated with increasing age and a lower mean (SD) forced expiratory volume/s (of that predicted) than in women with no urinary symptoms, at 26.9 (6.5) years and 53.5 (23.5)%, and 23.1 (5.4) years and 65.5 (23.2)%, respectively (P < 0.01 and P < 0.05, respectively). All incontinent women recorded stress UI; coughing, laughing and physical activity were associated with UI in 92%, 33% and 21% of the patients, respectively.
CONCLUSION: Stress UI is a common symptom in women with CF. As urine loss can be under-reported to the healthcare providers, women should be asked about incontinence as part of their routine follow-up. Pelvic floor muscle exercises are effective in treating stress UI and should be considered for those with CF and regular UI.

Entities:  

Mesh:

Year:  2001        PMID: 11446844     DOI: 10.1046/j.1464-410x.2001.02242.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  8 in total

Review 1.  Urinary incontinence in cystic fibrosis.

Authors:  Mary E Dodd; Hannah Langman
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

2.  Prevalence of Fecal Incontinence in Adults with Cystic Fibrosis.

Authors:  Alban Benezech; Nadine Desmazes-Dufeu; Karine Baumstarck; Michel Bouvier; Bérengère Coltey; Martine Reynaud-Gaubert; Véronique Vitton
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

3.  Prevalence and impact of pelvic floor dysfunction in an adult cystic fibrosis population: a questionnaire survey.

Authors:  Rebecca Chambers; Adam Lucht; Aisling Reihill; Judith Hough
Journal:  Int Urogynecol J       Date:  2016-10-13       Impact factor: 2.894

Review 4.  Pregnancy and cystic fibrosis: Approach to contemporary management.

Authors:  James Geake; George Tay; Leonie Callaway; Scott C Bell
Journal:  Obstet Med       Date:  2014-11-07

5.  Physiotherapeutic management strategies for the treatment of cystic fibrosis in adults.

Authors:  Tracey Daniels
Journal:  J Multidiscip Healthc       Date:  2010-11-19

6.  Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline.

Authors:  Brenda M Button; Christine Wilson; Ruth Dentice; Narelle S Cox; Anna Middleton; Esta Tannenbaum; Jennifer Bishop; Robyn Cobb; Kate Burton; Michelle Wood; Fiona Moran; Ryan Black; Summar Bowen; Rosemary Day; Julie Depiazzi; Katherine Doiron; Michael Doumit; Tiffany Dwyer; Alison Elliot; Louise Fuller; Kathleen Hall; Matthew Hutchins; Melinda Kerr; Annemarie L Lee; Christina Mans; Lauren O'Connor; Ranjana Steward; Angela Potter; Tshepo Rasekaba; Rebecca Scoones; Ben Tarrant; Nathan Ward; Samantha West; Dianne White; Lisa Wilson; Jamie Wood; Anne E Holland
Journal:  Respirology       Date:  2016-04-18       Impact factor: 6.424

7.  Prevalence of Pelvic Incontinence in Patients With Cystic Fibrosis.

Authors:  Fatima Neemuchwala; Fahmida Ahmed; Samya Z Nasr
Journal:  Glob Pediatr Health       Date:  2017-11-28

8.  Breathlessness is associated with urinary incontinence in men: A community-based study.

Authors:  Fumi Hirayama; Andy H Lee; Tetsuo Hiramatsu; Yoshimasa Tanikawa
Journal:  BMC Pulm Med       Date:  2010-01-06       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.